COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses | Nature
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination | medRxiv
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
One Pfizer/BioNTech jab gives '90% immunity' from Covid after 21 days | Vaccines and immunisation | The Guardian
Care needed' after getting Covid vaccine - BBC News
Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
Waning Immunity after the BNT162b2 Vaccine in Israel | NEJM
Chart: 28 Days Later: The Pfizer/BioNTech Vaccination Process | Statista
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers | Nature Communications
Pfizer Vaccine Immunity Timeline for… | Saint Regis Mohawk Tribe
Covid vaccines slash risk of infection, illness and death, UK studies find | Financial Times
Optimising the COVID-19 vaccination programme for maximum short- term impact
Pfizer vaccine can give early protection 12 days after one dose - SingHealth
Vaccinated with Pfizer-BioNTech or Moderna vaccines? Make sure to get your second shot : Oregon Health News Blog
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
S.Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shot | Reuters
Vaccines | Free Full-Text | A Peptide-Based Assay Discriminates Individual Antibody Response to the COVID-19 Pfizer/BioNTech mRNA Vaccine
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination | medRxiv
Several studies suggest single dose of vaccine provides strong protection for people who have recovered from COVID-19 - COVID-19 Immunity Task Force
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose - GOV.UK
COVID-19 Vaccines and Immunity: How Long Does it Take for the Vaccines to Provide Protection? | Newsroom | Weill Cornell Medicine
